Number of items: 6.
2017
Paulzen, Michael ,
Haen, Ekkehard,
Hiemke, Christoph,
Stegmann, Benedikt,
Lammertz, Sarah E.,
Gründer, Gerhard and
Schoretsanitis, Georgios
(2017)
Cytochrome P450-mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacy.
British Journal of Clinical Pharmacology 83 (8), pp. 1668-1675.
Fulltext not available.
Paulzen, Michael,
Schoretsanitis, Georgios ,
Stegmann, Benedikt,
Hiemke, Christoph,
Gründer, Gerhard,
Schruers, Koen R. J.,
Walther, Sebastian ,
Lammertz, Sarah E. and
Haen, Ekkehard
(2017)
Pharmacokinetic considerations in antipsychotic augmentation strategies: How to combine risperidone with low-potency antipsychotics.
Progress in Neuro-Psychopharmacology and Biological Psychiatry 76, pp. 101-106.
Fulltext not available.
2016
Paulzen, Michael ,
Haen, Ekkehard,
Stegmann, Benedikt,
Hiemke, Christoph,
Gründer, Gerhard,
Lammertz, Sarah E. and
Schoretsanitis, Georgios
(2016)
Body mass index (BMI) but not body weight is associated with changes in the metabolism of risperidone; A pharmacokinetics-based hypothesis.
Psychoneuroendocrinology 73, pp. 9-15.
Fulltext not available.
Schoretsanitis, Georgios,
Haen, Ekkehard,
Gründer, Gerhard,
Stegmann, Benedikt,
Schruers, Koen R. J.,
Hiemke, Christoph,
Lammertz, Sarah E. and
Paulzen, Michael
(2016)
Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment.
Journal of Clinical Psychopharmacology 36 (6), pp. 554-561.
Fulltext not available.
Schoretsanitis, Georgios ,
Stegmann, Benedikt,
Hiemke, Christoph,
Gründer, Gerhard,
Schruers, Koen R. J.,
Walther, Sebastian ,
Lammertz, Sarah E.,
Haen, Ekkehard and
Paulzen, Michael
(2016)
Pharmacokinetic patterns of risperidone-associated adverse drug reactions.
European Journal of Clinical Pharmacology 72 (9), pp. 1091-1098.
Fulltext not available.
Schoretsanitis, Georgios,
Haen, Ekkehard,
Hiemke, Christoph,
Gründer, Gerhard,
Stegmann, Benedikt,
Schruers, Koen R. J.,
Veselinovic, Tanja,
Lammertz, Sarah E. and
Paulzen, Michael
(2016)
Risperidone-induced extrapyramidal side effects.
International Clinical Psychopharmacology 31 (5), pp. 259-264.
Fulltext not available.
This list was generated on Mon Dec 9 10:31:07 2024 CET.